Published Date: 02 Mar 2023
The Medscape Ethics Survey investigated how internal medicine physicians view the ethical aspects of the response to medical assistance in dying, gender-related publications and materials.
Read Full NewsThe FDA is requiring new labeling across all GLP-1 receptor agonists to warn of a potential increased risk of a rare, vision-threatening optic nerve condition.
David Leehey, MD, says about half of the 2376 enrolled veterans were taking an SGLT2 inhibitor at baseline.
1.
No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma
2.
Study finds common genetic target may halt breast cancer cell growth
3.
New study highlights success of financial toxicity tumor board in reducing cancer treatment costs
4.
Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma
5.
Can Concurrent Boost Safely Shorten Breast Cancer Radiation?
1.
Different Types of Blood Dyscrasias
2.
Building Bridges between Heart and Cancer Care: A Comprehensive Guide to Cardio-Oncology Clinics
3.
Neutrophil Profiling and AI Rewrites Cancer Diagnosis
4.
Environmental Exposure Signatures in Cancer Risk
5.
Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
3.
The Role of Platelets in Normal Blood Clotting
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation